| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72893-003-01 | 72893-003 | HUMAN PRESCRIPTION DRUG | Folotyn | pralatrexate | INJECTION | INTRAVENOUS | 20090924 | N/A | NDA | NDA022468 | Acrotech Biopharma Inc | PRALATREXATE | 20 mg/mL | 1 VIAL in 1 CARTON (72893-003-01) / 1 mL in 1 VIAL |
| 72893-005-01 | 72893-005 | HUMAN PRESCRIPTION DRUG | Folotyn | pralatrexate | INJECTION | INTRAVENOUS | 20090924 | N/A | NDA | NDA022468 | Acrotech Biopharma Inc | PRALATREXATE | 40 mg/2mL | 1 VIAL in 1 CARTON (72893-005-01) / 2 mL in 1 VIAL |
| 65219-550-01 | 65219-550 | HUMAN PRESCRIPTION DRUG | Pralatrexate | Pralatrexate | INJECTION | INTRAVENOUS | 20221115 | N/A | NDA AUTHORIZED GENERIC | NDA022468 | Fresenius Kabi USA, LLC | PRALATREXATE | 20 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-550-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
| 65219-552-02 | 65219-552 | HUMAN PRESCRIPTION DRUG | Pralatrexate | Pralatrexate | INJECTION | INTRAVENOUS | 20221115 | N/A | NDA AUTHORIZED GENERIC | NDA022468 | Fresenius Kabi USA, LLC | PRALATREXATE | 40 mg/2mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-552-02) / 2 mL in 1 VIAL, SINGLE-DOSE |